[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610439":3},{"organization":4,"outcomesModule":7,"designInfo":92,"detailedDescription":98,"studyPopulation":91,"armGroups":99,"interventions":124,"overallOfficials":154,"centralContacts":158,"locations":164,"responsibleParty":810,"collaborators":812,"id":815,"slug":816,"hasResults":817,"nctId":818,"briefTitle":819,"officialTitle":820,"acronym":91,"eligibilityCriteria":821,"healthyVolunteers":817,"sex":822,"minAge":823,"maxAge":91,"enrollmentInfo":824,"targetDuration":91,"studyType":827,"phases":828,"briefSummary":831,"conditions":832,"keywords":91,"overallStatus":167,"whyStopped":91,"lastUpdateSubmitDate":834,"lastUpdatePostDateStruct":835,"startDateStruct":838,"completionDateStruct":840,"leadSponsor":842,"locationsCount":843},{"fullName":5,"class":6},"Merck Sharp & Dohme LLC","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":23,"otherOutcomes":91},[9,13,17,20],{"measure":10,"description":11,"timeFrame":12},"Number of Participants Who Experience an Adverse Event (AE)","An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who experience an AE will be reported.","Up to approximately 58 months",{"measure":14,"description":15,"timeFrame":16},"Number of Participants Who Experience One or More Dose-Limiting Toxicities (DLTs)","DLT will be defined as any drug-related AE observed during the DLT evaluation period (up to 21 days) that meets the protocol-specified DLT criteria. The number of participants who experience at least one DLT will be presented.","Up to approximately 21 days",{"measure":18,"description":19,"timeFrame":12},"Number of Participants Who Discontinue Study Intervention Due to an AE","An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who discontinue study intervention due to an AE will be reported.",{"measure":21,"description":22,"timeFrame":12},"Objective Response Rate (ORR)","ORR is defined as the percentage of participants with Complete Response (CR: disappearance of all target lesions) or Partial Response (PR: at least a 30% decrease in the sum of diameters of target lesions) per Response Evaluation Criteria In Solid Tumors Version 1.1 (RECIST 1.1). The percentage of participants who experience CR or PR as assessed by Blinded Independent Central Review (BICR) will be presented.",[24,27,30,33,36,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85,88],{"measure":25,"description":26,"timeFrame":12},"Disease Control Rate (DCR)","DCR is defined, per RECIST 1.1, as the percentage of participants who have a CR or PR or Stable Disease (SD: Neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease (PD: At least a 20% increase in the sum of diameters of target lesions and an absolute increase of at least 5 mm. The appearance of one or more new lesions is also considered PD). The DCR as assessed by BICR will be presented.",{"measure":28,"description":29,"timeFrame":12},"Duration of Response (DOR)","For participants who demonstrate a confirmed CR or PR per RECIST 1.1, DOR is defined as the time from first documented evidence of CR or PR until PD or death due to any cause, whichever occurs first. Per RECIST 1.1, PD is defined as at least a 20% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of ≥5 mm. The appearance of one or more new lesions is also considered PD. DOR as assessed by BICR will be presented.",{"measure":31,"description":32,"timeFrame":12},"Progression-Free Survival (PFS)","PFS is defined as the time from randomization (Part B for Arms 2-4) or from the first dose of study treatment (safety run-in Part A and Arm 1 Part B) to the first documented PD or death due to any cause, whichever occurs first as assessed by RECIST 1.1. PD is defined as ≥20% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of ≥5 mm. The appearance of one or more new lesions is also considered PD. PFS as assessed by BICR will be presented.",{"measure":34,"description":35,"timeFrame":12},"Overall Survival (OS)","OS is defined as the time from the first dose of study treatment (Part A and Arm 1 Part B) or randomization (Part B for Arms 2-4) to death due to any cause.",{"measure":37,"description":38,"timeFrame":39},"Area Under the Concentration-Time Curve Over the Dosing Interval t (AUCt) of Gocatamig","Blood samples will be collected at multiple time points to determine the AUCt of the drug gocatamig.","At designated time points (up to approximately 58 months)",{"measure":41,"description":42,"timeFrame":39},"AUCt of I-DXd","Blood samples will be collected at multiple time points to determine the AUCt of the drug I-DXd.",{"measure":44,"description":45,"timeFrame":39},"AUCt of Deruxtecan (DXd)","DXd is the payload released from the drug I-DXd. Blood samples will be collected at multiple time points to determine the AUCt of the drug payload DXd.",{"measure":47,"description":48,"timeFrame":39},"AUCt of Anti-B7-H3 Antibody","Blood samples will be collected at multiple time points to determine the AUCt of the anti-B7-H3 antibody.",{"measure":50,"description":51,"timeFrame":39},"Area Under the Steady-State Concentration-Time Curve Over the Dosing Interval t (AUCt,ss) of Gocatamig","Blood samples will be collected at multiple time points to determine the AUCt,ss of the drug gocatamig.",{"measure":53,"description":54,"timeFrame":39},"AUCt,ss of I-DXd","Blood samples will be collected at multiple time points to determine the AUCt,ss of the drug I-DXd.",{"measure":56,"description":57,"timeFrame":39},"AUCt,ss of DXd","DXd is the payload released from the drug I-DXd. Blood samples will be collected at multiple time points to determine the AUCt,ss of the drug payload DXd.",{"measure":59,"description":60,"timeFrame":39},"AUCt,ss of Anti-B7-H3 Antibody","Blood samples will be collected at multiple time points to determine the AUCt,ss of the anti-B7-H3 antibody.",{"measure":62,"description":63,"timeFrame":39},"Maximum Concentration (Cmax) of Gocatamig","Blood samples will be collected at multiple time points to determine Cmax of the drug gocatamig.",{"measure":65,"description":66,"timeFrame":39},"Cmax of I-DXd","Blood samples will be collected at multiple time points to determine Cmax of the drug I-DXd.",{"measure":68,"description":69,"timeFrame":39},"Cmax of DXd","DXd is the payload released from the drug I-DXd. Blood samples will be collected at multiple time points to determine Cmax of the drug payload DXd.",{"measure":71,"description":72,"timeFrame":39},"Cmax of Anti-B7-H3 Antibody","Blood samples will be collected at multiple time points to determine Cmax of the anti-B7-H3 antibody.",{"measure":74,"description":75,"timeFrame":39},"Trough Concentration (Ctrough) of Gocatamig","Blood samples will be collected at multiple time points to determine Ctrough of the drug gocatamig.",{"measure":77,"description":78,"timeFrame":39},"Ctrough of I-DXd","Blood samples will be collected at multiple time points to determine Ctrough of the drug I-DXd.",{"measure":80,"description":81,"timeFrame":39},"Ctrough of DXd","DXd is the payload released from the drug I-DXd. Blood samples will be collected at multiple time points to determine Ctrough of the drug payload DXd.",{"measure":83,"description":84,"timeFrame":39},"Ctrough of Anti-B7-H3 Antibody","Blood samples will be collected at multiple time points to determine Ctrough of the anti-B7-H3 antibody.",{"measure":86,"description":87,"timeFrame":39},"Incidence of Anti-Drug Antibodies (ADAs) Against Gocatamig","Blood samples will be collected at multiple time points to determine the ADA response to gocatamig. The incidence of ADAs for gocatamig will be presented.",{"measure":89,"description":90,"timeFrame":39},"Incidence of ADAs Against I-DXd","Blood samples will be collected at multiple time points to determine the ADA response to I-DXd. The incidence of ADAs for I-DXd will be presented.",null,{"allocation":93,"interventionModel":94,"interventionModelDescription":91,"primaryPurpose":95,"observationalModel":91,"timePerspective":91,"maskingInfo":96},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":97,"maskingDescription":91,"whoMasked":91},"NONE","In Part A, participants will be allocated to Arm 1 or Arm 2 per investigator's discretion. In Part B, participants will be allocated to Arm 1 per investigator's discretion and randomized to Arms 2, 3, and 4.",[100,108,112,117],{"label":101,"type":102,"description":103,"interventionNames":104},"Arm 1, Parts A and B: Gocataming + I-DXd","EXPERIMENTAL","Participants who completed standard of care (SOC) induction chemotherapy with concurrent approved anti-programmed cell death 1\u002Fligand 1 protein (anti-PD-1\u002FL1) treatment for ES-SCLC and did not have disease progression per investigator discretion, will receive gocatamig and I-DXd in the maintenance phase, until documented disease progression or meeting other study discontinuation criteria.",[105,106,107],"Drug: Gocatamig","Drug: I-DXd","Drug: Rescue Medications",{"label":109,"type":102,"description":110,"interventionNames":111},"Arm 2, Parts A and B: Gocataming + I-DXd","Participants who did not receive prior systemic treatment for ES-SCLC will receive gocatamig and I-DXd during induction and maintenance phases, until documented disease progression or meeting other study discontinuation criteria.",[105,106,107],{"label":113,"type":102,"description":114,"interventionNames":115},"Arm 3, Part B: Gocataming + I-DXd → gocatamig + atezolizumab","Participants who did not receive prior systemic treatment for ES-SCLC will receive gocatamig and I-DXd in the induction phase, followed by gocatamig and atezolizumab in the maintenance phase, until documented disease progression or meeting other study discontinuation criteria.",[105,106,116,107],"Drug: Atezolizumab",{"label":118,"type":119,"description":120,"interventionNames":121},"Arm 4, Part B: Carboplatin + etoposide + atezolizumab → atezolizumab","ACTIVE_COMPARATOR","Participants who did not receive prior systemic treatment for ES-SCLC will receive SOC (carboplatin + etoposide + atezolizumab) in the induction phase, followed by atezolizumab in the maintenance phase, until documented disease progression or meeting other study discontinuation criteria.",[116,122,123],"Drug: Carboplatin","Drug: Etoposide",[125,134,141,144,147,150],{"type":126,"name":127,"description":128,"armGroupLabels":129,"otherNames":130},"DRUG","Gocatamig","Intravenous (IV) administration",[101,109,113],[131,132,133],"MK-6070","HPN328","DS-3280",{"type":126,"name":135,"description":136,"armGroupLabels":137,"otherNames":138},"I-DXd","IV administration",[101,109,113],[139,140],"MK-2400","DS-7300a",{"type":126,"name":142,"description":136,"armGroupLabels":143,"otherNames":91},"Atezolizumab",[113,118],{"type":126,"name":145,"description":136,"armGroupLabels":146,"otherNames":91},"Carboplatin",[118],{"type":126,"name":148,"description":136,"armGroupLabels":149,"otherNames":91},"Etoposide",[118],{"type":126,"name":151,"description":152,"armGroupLabels":153,"otherNames":91},"Rescue Medications","Participants will receive rescue medications at the investigator's discretion. Recommended rescue medications include tocilizumab for treatment of cytokine release syndrome (CRS); dexamethasone, acetaminophen, and diphenhydramine for CRS\u002Finfusion-related reaction (IRR) prophylaxis; and 5-hydroxytryptamine 3 (5-HT3) receptor antagonist, neurokinin 1 (NK-1) receptor antagonist, and corticosteroid for prevention of nausea and vomiting.",[101,109,113],[155],{"name":156,"affiliation":5,"role":157},"Medical Director","STUDY_DIRECTOR",[159],{"name":160,"role":161,"phone":162,"phoneExt":91,"email":163},"Toll Free Number","CONTACT","1-888-577-8839","Trialsites@msd.com",[165,183,196,209,222,235,248,261,274,287,299,311,324,337,347,359,372,387,396,405,420,433,446,458,471,484,497,510,522,537,550,565,574,583,595,603,617,629,644,656,668,683,696,705,714,723,738,751,763,775,785,797],{"facility":166,"status":167,"city":168,"state":169,"zip":170,"country":171,"countryCode":172,"cosmosGeoPoint":173,"geoPoint":178,"contacts":179},"Providence Medical Foundation ( Site 0124)","RECRUITING","Santa Rosa","California","95403","United States","US",{"type":174,"coordinates":175},"Point",[176,177],-122.71443,38.44047,{"lat":177,"lon":176},[180],{"name":181,"role":161,"phone":182,"phoneExt":91,"email":91},"Study Coordinator","707-521-3830",{"facility":184,"status":167,"city":185,"state":186,"zip":187,"country":171,"countryCode":172,"cosmosGeoPoint":188,"geoPoint":192,"contacts":193},"University of Colorado, Anschutz Cancer Pavilion ( Site 0125)","Aurora","Colorado","80045",{"type":174,"coordinates":189},[190,191],-104.83192,39.72943,{"lat":191,"lon":190},[194],{"name":181,"role":161,"phone":195,"phoneExt":91,"email":91},"303-724-4304",{"facility":197,"status":167,"city":198,"state":199,"zip":200,"country":171,"countryCode":172,"cosmosGeoPoint":201,"geoPoint":205,"contacts":206},"Orlando Health Cancer Institute ( Site 0108)","Orlando","Florida","32806",{"type":174,"coordinates":202},[203,204],-81.37924,28.53834,{"lat":204,"lon":203},[207],{"name":181,"role":161,"phone":208,"phoneExt":91,"email":91},"321-841-1869",{"facility":210,"status":167,"city":211,"state":212,"zip":213,"country":171,"countryCode":172,"cosmosGeoPoint":214,"geoPoint":218,"contacts":219},"Saint Elizabeth Medical Center Edgewood ( Site 0112)","Edgewood","Kentucky","41017",{"type":174,"coordinates":215},[216,217],-84.58189,39.01867,{"lat":217,"lon":216},[220],{"name":181,"role":161,"phone":221,"phoneExt":91,"email":91},"859-301-4000",{"facility":223,"status":167,"city":224,"state":225,"zip":226,"country":171,"countryCode":172,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"Washington University School of Medicine ( Site 0134)","St Louis","Missouri","63110",{"type":174,"coordinates":228},[229,230],-90.19789,38.62727,{"lat":230,"lon":229},[233],{"name":181,"role":161,"phone":234,"phoneExt":91,"email":91},"314-747-1171",{"facility":236,"status":167,"city":237,"state":238,"zip":239,"country":171,"countryCode":172,"cosmosGeoPoint":240,"geoPoint":244,"contacts":245},"John Theurer Cancer Center at Hackensack University Medical Center ( Site 0101)","Hackensack","New Jersey","07601",{"type":174,"coordinates":241},[242,243],-74.04347,40.88593,{"lat":243,"lon":242},[246],{"name":181,"role":161,"phone":247,"phoneExt":91,"email":91},"551-996-5955",{"facility":249,"status":167,"city":250,"state":251,"zip":252,"country":171,"countryCode":172,"cosmosGeoPoint":253,"geoPoint":257,"contacts":258},"Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107)","Portland","Oregon","97213",{"type":174,"coordinates":254},[255,256],-122.67621,45.52345,{"lat":256,"lon":255},[259],{"name":181,"role":161,"phone":260,"phoneExt":91,"email":91},"503-215-5696",{"facility":262,"status":167,"city":263,"state":264,"zip":265,"country":171,"countryCode":172,"cosmosGeoPoint":266,"geoPoint":270,"contacts":271},"Avera Cancer Institute- Research ( Site 0104)","Sioux Falls","South Dakota","57105",{"type":174,"coordinates":267},[268,269],-96.72796,43.54369,{"lat":269,"lon":268},[272],{"name":181,"role":161,"phone":273,"phoneExt":91,"email":91},"605-322-6900",{"facility":275,"status":167,"city":276,"state":277,"zip":278,"country":171,"countryCode":172,"cosmosGeoPoint":279,"geoPoint":283,"contacts":284},"The University of Tennessee Medical Center ( Site 0120)","Knoxville","Tennessee","37920",{"type":174,"coordinates":280},[281,282],-83.92074,35.96064,{"lat":282,"lon":281},[285],{"name":181,"role":161,"phone":286,"phoneExt":91,"email":91},"865-305-8780",{"facility":288,"status":167,"city":289,"state":277,"zip":290,"country":171,"countryCode":172,"cosmosGeoPoint":291,"geoPoint":295,"contacts":296},"Lt. Col. Luke Weathers, Jr. VA Medical Center ( Site 0133)","Memphis","38105",{"type":174,"coordinates":292},[293,294],-90.04898,35.14953,{"lat":294,"lon":293},[297],{"name":181,"role":161,"phone":298,"phoneExt":91,"email":91},"901-351-3673",{"facility":300,"status":167,"city":301,"state":277,"zip":302,"country":171,"countryCode":172,"cosmosGeoPoint":303,"geoPoint":307,"contacts":308},"SCRI Oncology Partners ( Site 7000)","Nashville","37203",{"type":174,"coordinates":304},[305,306],-86.78444,36.16589,{"lat":306,"lon":305},[309],{"name":181,"role":161,"phone":310,"phoneExt":91,"email":91},"844-482-4812",{"facility":312,"status":167,"city":313,"state":314,"zip":315,"country":171,"countryCode":172,"cosmosGeoPoint":316,"geoPoint":320,"contacts":321},"Houston Methodist Hospital - Houston Methodist Neal Cancer Center ( Site 0113)","Houston","Texas","77030",{"type":174,"coordinates":317},[318,319],-95.36327,29.76328,{"lat":319,"lon":318},[322],{"name":181,"role":161,"phone":323,"phoneExt":91,"email":91},"646-407-2086",{"facility":325,"status":167,"city":326,"state":327,"zip":328,"country":171,"countryCode":172,"cosmosGeoPoint":329,"geoPoint":333,"contacts":334},"University of Virginia Health System ( Site 0122)","Charlottesville","Virginia","22908",{"type":174,"coordinates":330},[331,332],-78.47668,38.02931,{"lat":332,"lon":331},[335],{"name":181,"role":161,"phone":336,"phoneExt":91,"email":91},"434-924-4251",{"facility":338,"status":167,"city":339,"state":340,"zip":341,"country":342,"countryCode":343,"cosmosGeoPoint":91,"geoPoint":91,"contacts":344},"CEMIC ( Site 1903)","Caba.","Buenos Aires","C1431FWO","Argentina","AR",[345],{"name":181,"role":161,"phone":346,"phoneExt":91,"email":91},"+5491160006609",{"facility":348,"status":167,"city":349,"state":340,"zip":350,"country":342,"countryCode":343,"cosmosGeoPoint":351,"geoPoint":355,"contacts":356},"Hospital Austral ( Site 1901)","Pilar","B1629AHJ",{"type":174,"coordinates":352},[353,354],-58.91398,-34.45867,{"lat":354,"lon":353},[357],{"name":181,"role":161,"phone":358,"phoneExt":91,"email":91},"+54911 38018573",{"facility":360,"status":167,"city":361,"state":362,"zip":363,"country":342,"countryCode":343,"cosmosGeoPoint":364,"geoPoint":368,"contacts":369},"Sanatorio Parque ( Site 1900)","Rosario","Santa Fe Province","S2000DSV",{"type":174,"coordinates":365},[366,367],-60.63932,-32.94682,{"lat":367,"lon":366},[370],{"name":181,"role":161,"phone":371,"phoneExt":91,"email":91},"+5493416955611",{"facility":373,"status":167,"city":374,"state":375,"zip":376,"country":377,"countryCode":378,"cosmosGeoPoint":379,"geoPoint":383,"contacts":384},"FALP ( Site 0200)","Santiago","Region M. de Santiago","7500921","Chile","CL",{"type":174,"coordinates":380},[381,382],-70.64827,-33.45694,{"lat":382,"lon":381},[385],{"name":181,"role":161,"phone":386,"phoneExt":91,"email":91},"56224205098",{"facility":388,"status":167,"city":374,"state":375,"zip":389,"country":377,"countryCode":378,"cosmosGeoPoint":390,"geoPoint":392,"contacts":393},"Pontificia Universidad Catolica de Chile ( Site 0202)","8330032",{"type":174,"coordinates":391},[381,382],{"lat":382,"lon":381},[394],{"name":181,"role":161,"phone":395,"phoneExt":91,"email":91},"+56934271024",{"facility":397,"status":167,"city":374,"state":375,"zip":398,"country":377,"countryCode":378,"cosmosGeoPoint":399,"geoPoint":401,"contacts":402},"Bradfordhill ( Site 0201)","8420383",{"type":174,"coordinates":400},[381,382],{"lat":382,"lon":381},[403],{"name":181,"role":161,"phone":404,"phoneExt":91,"email":91},"56229490970",{"facility":406,"status":167,"city":407,"state":408,"zip":409,"country":410,"countryCode":411,"cosmosGeoPoint":412,"geoPoint":416,"contacts":417},"Beijing Cancer Hospital ( Site 1604)","Beijing","Beijing Municipality","100142","China","CN",{"type":174,"coordinates":413},[414,415],116.39723,39.9075,{"lat":415,"lon":414},[418],{"name":181,"role":161,"phone":419,"phoneExt":91,"email":91},"010-88121122",{"facility":421,"status":167,"city":422,"state":423,"zip":424,"country":410,"countryCode":411,"cosmosGeoPoint":425,"geoPoint":429,"contacts":430},"Fujian Provincial Cancer Hospital ( Site 1607)","Fuzhou","Fujian","350014",{"type":174,"coordinates":426},[427,428],119.30611,26.06139,{"lat":428,"lon":427},[431],{"name":181,"role":161,"phone":432,"phoneExt":91,"email":91},"+86059183660063",{"facility":434,"status":167,"city":435,"state":436,"zip":437,"country":410,"countryCode":411,"cosmosGeoPoint":438,"geoPoint":442,"contacts":443},"Southern Medical University Nanfang Hospital ( Site 1608)","Guangzhou","Guangdong","510515",{"type":174,"coordinates":439},[440,441],113.25,23.11667,{"lat":441,"lon":440},[444],{"name":181,"role":161,"phone":445,"phoneExt":91,"email":91},"+86 13632102245",{"facility":447,"status":167,"city":448,"state":436,"zip":449,"country":410,"countryCode":411,"cosmosGeoPoint":450,"geoPoint":454,"contacts":455},"Jiangmen Central Hospital ( Site 1611)","Jiangmen","529000",{"type":174,"coordinates":451},[452,453],113.08333,22.58333,{"lat":453,"lon":452},[456],{"name":181,"role":161,"phone":457,"phoneExt":91,"email":91},"+86 13702282382",{"facility":459,"status":167,"city":460,"state":461,"zip":462,"country":410,"countryCode":411,"cosmosGeoPoint":463,"geoPoint":467,"contacts":468},"The First Affiliated Hospital of Nanchang University ( Site 1610)","Nanchang","Jiangxi","330209",{"type":174,"coordinates":464},[465,466],115.85306,28.68396,{"lat":466,"lon":465},[469],{"name":181,"role":161,"phone":470,"phoneExt":91,"email":91},"+86079186319453",{"facility":472,"status":167,"city":473,"state":474,"zip":475,"country":410,"countryCode":411,"cosmosGeoPoint":476,"geoPoint":480,"contacts":481},"Shanghai East Hospital ( Site 1600)","Shanghai","Shanghai Municipality","200000",{"type":174,"coordinates":477},[478,479],121.45806,31.22222,{"lat":479,"lon":478},[482],{"name":181,"role":161,"phone":483,"phoneExt":91,"email":91},"021-20334534",{"facility":485,"status":167,"city":486,"state":487,"zip":488,"country":410,"countryCode":411,"cosmosGeoPoint":489,"geoPoint":493,"contacts":494},"Sichuan Cancer hospital. ( Site 1609)","Chengdu","Sichuan","610213",{"type":174,"coordinates":490},[491,492],104.06667,30.66667,{"lat":492,"lon":491},[495],{"name":181,"role":161,"phone":496,"phoneExt":91,"email":91},"18180900912",{"facility":498,"status":167,"city":499,"state":500,"zip":501,"country":410,"countryCode":411,"cosmosGeoPoint":502,"geoPoint":506,"contacts":507},"The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 1602)","Hangzhou","Zhejiang","310003",{"type":174,"coordinates":503},[504,505],120.16142,30.29365,{"lat":505,"lon":504},[508],{"name":181,"role":161,"phone":509,"phoneExt":91,"email":91},"+8657187236560",{"facility":511,"status":167,"city":512,"state":500,"zip":513,"country":410,"countryCode":411,"cosmosGeoPoint":514,"geoPoint":518,"contacts":519},"Taizhou Hospital of Zhejiang Province ( Site 1601)","Taizhou","317000",{"type":174,"coordinates":515},[516,517],121.43312,28.66266,{"lat":517,"lon":516},[520],{"name":181,"role":161,"phone":521,"phoneExt":91,"email":91},"0576-85199810",{"facility":523,"status":167,"city":524,"state":525,"zip":526,"country":527,"countryCode":528,"cosmosGeoPoint":529,"geoPoint":533,"contacts":534},"Universitaetsklinikum Tuebingen-Department of Internal Medicine VIII - Medical Oncology, ECTU, Pne ( Site 0401)","Tübingen","Baden-Wurttemberg","72076","Germany","DE",{"type":174,"coordinates":530},[531,532],9.05222,48.52266,{"lat":532,"lon":531},[535],{"name":181,"role":161,"phone":536,"phoneExt":91,"email":91},"+4970712982795",{"facility":538,"status":167,"city":539,"state":540,"zip":541,"country":527,"countryCode":528,"cosmosGeoPoint":542,"geoPoint":546,"contacts":547},"Universitaetsklinikum Jena ( Site 0403)","Jena","Thuringia","07747",{"type":174,"coordinates":543},[544,545],11.5899,50.92878,{"lat":545,"lon":544},[548],{"name":181,"role":161,"phone":549,"phoneExt":91,"email":91},"+4936419324584",{"facility":551,"status":167,"city":552,"state":553,"zip":554,"country":555,"countryCode":556,"cosmosGeoPoint":557,"geoPoint":561,"contacts":562},"Errikos Dunant Hospital Center ( Site 0501)","Athens","Attica","115 26","Greece","GR",{"type":174,"coordinates":558},[559,560],23.72784,37.98376,{"lat":560,"lon":559},[563],{"name":181,"role":161,"phone":564,"phoneExt":91,"email":91},"+302106972246",{"facility":566,"status":167,"city":552,"state":553,"zip":567,"country":555,"countryCode":556,"cosmosGeoPoint":568,"geoPoint":570,"contacts":571},"THORACIC GENERAL HOSPITAL OF ATHENS \"I SOTIRIA\" ( Site 0502)","115 27",{"type":174,"coordinates":569},[559,560],{"lat":560,"lon":559},[572],{"name":181,"role":161,"phone":573,"phoneExt":91,"email":91},"+302107700220",{"facility":575,"status":167,"city":552,"state":553,"zip":576,"country":555,"countryCode":556,"cosmosGeoPoint":577,"geoPoint":579,"contacts":580},"Athens Medical Center ( Site 0504)","151 25",{"type":174,"coordinates":578},[559,560],{"lat":560,"lon":559},[581],{"name":181,"role":161,"phone":582,"phoneExt":91,"email":91},"+302107464642",{"facility":584,"status":167,"city":585,"state":91,"zip":586,"country":555,"countryCode":556,"cosmosGeoPoint":587,"geoPoint":591,"contacts":592},"European Interbalkan Medical Center ( Site 0500)","Thessaloniki","570 01",{"type":174,"coordinates":588},[589,590],22.93493,40.64072,{"lat":590,"lon":589},[593],{"name":181,"role":161,"phone":594,"phoneExt":91,"email":91},"+302310400213",{"facility":596,"status":167,"city":585,"state":91,"zip":586,"country":555,"countryCode":556,"cosmosGeoPoint":597,"geoPoint":599,"contacts":600},"European Interbalkan Medical Center ( Site 0505)",{"type":174,"coordinates":598},[589,590],{"lat":590,"lon":589},[601],{"name":181,"role":161,"phone":602,"phoneExt":91,"email":91},"+302310390671",{"facility":604,"status":167,"city":605,"state":91,"zip":606,"country":607,"countryCode":608,"cosmosGeoPoint":609,"geoPoint":613,"contacts":614},"Rambam Health Care Campus ( Site 0602)","Haifa","3109601","Israel","IL",{"type":174,"coordinates":610},[611,612],34.99928,32.81303,{"lat":612,"lon":611},[615],{"name":181,"role":161,"phone":616,"phoneExt":91,"email":91},"+97247772688",{"facility":618,"status":167,"city":619,"state":91,"zip":620,"country":607,"countryCode":608,"cosmosGeoPoint":621,"geoPoint":625,"contacts":626},"Sheba Medical Center ( Site 0601)","Ramat Gan","5265601",{"type":174,"coordinates":622},[623,624],34.81065,32.08227,{"lat":624,"lon":623},[627],{"name":181,"role":161,"phone":628,"phoneExt":91,"email":91},"+97235303030",{"facility":630,"status":167,"city":631,"state":632,"zip":633,"country":634,"countryCode":635,"cosmosGeoPoint":636,"geoPoint":640,"contacts":641},"IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) \"Dino Amadori\" ( Site 0702)","Meldola","Forli-Cesena","47014","Italy","IT",{"type":174,"coordinates":637},[638,639],12.0626,44.12775,{"lat":639,"lon":638},[642],{"name":181,"role":161,"phone":643,"phoneExt":91,"email":91},"+39 0543 739100",{"facility":645,"status":167,"city":646,"state":91,"zip":647,"country":634,"countryCode":635,"cosmosGeoPoint":648,"geoPoint":652,"contacts":653},"Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0701)","Milan","20133",{"type":174,"coordinates":649},[650,651],12.59836,42.78235,{"lat":651,"lon":650},[654],{"name":181,"role":161,"phone":655,"phoneExt":91,"email":91},"00390223903665",{"facility":657,"status":167,"city":658,"state":91,"zip":659,"country":634,"countryCode":635,"cosmosGeoPoint":660,"geoPoint":664,"contacts":665},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0700)","Roma","00168",{"type":174,"coordinates":661},[662,663],11.10642,44.99364,{"lat":663,"lon":662},[666],{"name":181,"role":161,"phone":667,"phoneExt":91,"email":91},"00390630153446",{"facility":669,"status":167,"city":670,"state":671,"zip":672,"country":673,"countryCode":674,"cosmosGeoPoint":675,"geoPoint":679,"contacts":680},"Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 0902)","Warsaw","Masovian Voivodeship","02-781","Poland","PL",{"type":174,"coordinates":676},[677,678],21.01178,52.22977,{"lat":678,"lon":677},[681],{"name":181,"role":161,"phone":682,"phoneExt":91,"email":91},"+48225463066",{"facility":684,"status":167,"city":685,"state":91,"zip":686,"country":687,"countryCode":91,"cosmosGeoPoint":688,"geoPoint":692,"contacts":693},"Seoul National University Hospital ( Site 1402)","Seoul","03080","South Korea",{"type":174,"coordinates":689},[690,691],126.9784,37.566,{"lat":691,"lon":690},[694],{"name":181,"role":161,"phone":695,"phoneExt":91,"email":91},"82-2-2072-3559",{"facility":697,"status":167,"city":685,"state":91,"zip":698,"country":687,"countryCode":91,"cosmosGeoPoint":699,"geoPoint":701,"contacts":702},"Severance Hospital Yonsei University Health System ( Site 1403)","03722",{"type":174,"coordinates":700},[690,691],{"lat":691,"lon":690},[703],{"name":181,"role":161,"phone":704,"phoneExt":91,"email":91},"+82215991004",{"facility":706,"status":167,"city":685,"state":91,"zip":707,"country":687,"countryCode":91,"cosmosGeoPoint":708,"geoPoint":710,"contacts":711},"Asan Medical Center ( Site 1404)","05505",{"type":174,"coordinates":709},[690,691],{"lat":691,"lon":690},[712],{"name":181,"role":161,"phone":713,"phoneExt":91,"email":91},"+82230103215",{"facility":715,"status":167,"city":685,"state":91,"zip":716,"country":687,"countryCode":91,"cosmosGeoPoint":717,"geoPoint":719,"contacts":720},"Samsung Medical Center ( Site 1401)","06351",{"type":174,"coordinates":718},[690,691],{"lat":691,"lon":690},[721],{"name":181,"role":161,"phone":722,"phoneExt":91,"email":91},"02-3410-1795",{"facility":724,"status":167,"city":725,"state":726,"zip":727,"country":728,"countryCode":729,"cosmosGeoPoint":730,"geoPoint":734,"contacts":735},"Hospital San Pedro ( Site 1004)","Logroño","La Rioja","26006","Spain","ES",{"type":174,"coordinates":731},[732,733],-2.45115,42.46615,{"lat":733,"lon":732},[736],{"name":181,"role":161,"phone":737,"phoneExt":91,"email":91},"941278760",{"facility":739,"status":167,"city":740,"state":741,"zip":742,"country":728,"countryCode":729,"cosmosGeoPoint":743,"geoPoint":747,"contacts":748},"Hospital Universitario Insular de Gran Canaria ( Site 1002)","Las Palmas de Gran Canaria","Las Palmas","35016",{"type":174,"coordinates":744},[745,746],-15.41573,28.10178,{"lat":746,"lon":745},[749],{"name":181,"role":161,"phone":750,"phoneExt":91,"email":91},"+34 928441738",{"facility":752,"status":167,"city":753,"state":91,"zip":754,"country":728,"countryCode":729,"cosmosGeoPoint":755,"geoPoint":759,"contacts":760},"Hospital Universitari Vall d'Hebron ( Site 1001)","Barcelona","08035",{"type":174,"coordinates":756},[757,758],2.15899,41.38879,{"lat":758,"lon":757},[761],{"name":181,"role":161,"phone":762,"phoneExt":91,"email":91},"+34932746000",{"facility":764,"status":167,"city":765,"state":91,"zip":766,"country":728,"countryCode":729,"cosmosGeoPoint":767,"geoPoint":771,"contacts":772},"Hospital Universitario Gregorio Maranon ( Site 1003)","Madrid","28007",{"type":174,"coordinates":768},[769,770],-3.70256,40.4165,{"lat":770,"lon":769},[773],{"name":181,"role":161,"phone":774,"phoneExt":91,"email":91},"917996984",{"facility":776,"status":167,"city":777,"state":778,"zip":779,"country":780,"countryCode":781,"cosmosGeoPoint":91,"geoPoint":91,"contacts":782},"Faculty of Medicine Siriraj Hospital ( Site 3000)","Bangkoknoi","Bangkok","10700","Thailand","TH",[783],{"name":181,"role":161,"phone":784,"phoneExt":91,"email":91},"+6624194488",{"facility":786,"status":167,"city":787,"state":778,"zip":788,"country":780,"countryCode":781,"cosmosGeoPoint":789,"geoPoint":793,"contacts":794},"Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 3002)","Dusit","10300",{"type":174,"coordinates":790},[791,792],100.51958,13.77706,{"lat":792,"lon":791},[795],{"name":181,"role":161,"phone":796,"phoneExt":91,"email":91},"+6622443000",{"facility":798,"status":167,"city":799,"state":800,"zip":801,"country":780,"countryCode":781,"cosmosGeoPoint":802,"geoPoint":806,"contacts":807},"Songklanagarind hospital ( Site 3001)","Hat Yai","Changwat Songkhla","90110",{"type":174,"coordinates":803},[804,805],100.47668,7.00836,{"lat":805,"lon":804},[808],{"name":181,"role":161,"phone":809,"phoneExt":91,"email":91},"+6674451469",{"type":811,"investigatorFullName":91,"investigatorTitle":91,"investigatorAffiliation":91,"oldNameTitle":91,"oldOrganization":91},"SPONSOR",[813],{"name":814,"class":6},"Daiichi Sankyo","100610439","phase-1-a-clinical-study-of-gocatamig-mk-6070-and-infinatamab-deruxtecan-mk-2400-in-people-with-small-cell-lung-cancer-mk-6070-003-100610439",false,"NCT07227597","A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)","A Phase 1b\u002F2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer","Inclusion Criteria:\n\nThe main inclusion criteria include but are not limited to the following:\n\n* Has a histologically or cytologically confirmed diagnosis of extensive-stage small cell lung cancer (ES-SCLC)\n* For participants receiving gocatamig + ifinatamab deruxtecan (I-DXd) in maintenance only:\n\n  * Completed 3 to 4 cycles of platinum + etoposide chemotherapy with concurrent approved anti-programmed cell death 1\u002FLigand 1 (anti PD-1\u002FL1) as first line (1L) treatment of ES-SCLC within 6 weeks prior to enrollment\n  * No radiological disease progression per Response Evaluation Criteria In Solid Tumors version 1.1 (RECIST 1.1)\n  * No other prior systemic ES-SCLC therapy allowed\n  * Rechallenge therapy counts as an additional line and leads to exclusion\n* For participants receiving gocatamig + I-DXd in induction and maintenance, or gocatamig + I-DXd in induction followed by gocatamig + atezolizumab in maintenance, or carboplatin + etoposide + atezolizumab in induction followed by atezolizumab in maintenance: No prior systemic ES-SCLC treatment allowed\n* Applicable to all participants: prior limited-stage small cell lung cancer (SCLC) is allowed if \\> 6 months have passed since the end of previous therapy and progression\n* Must be able to provide a pretreatment archival tumor tissue sample or newly obtained core, incisional, or excisional biopsy of a tumor lesion not previously irradiated\n* Measurable disease by RECIST 1.1 as assessed by the local site investigator\u002Fradiology. Lesions situated in a previously irradiated area are considered measurable if growth has been shown in such lesions since the completion of radiation\n\nExclusion Criteria:\n\nThe main exclusion criteria include but are not limited to the following:\n\n* Has pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures\n* Has any history of interstitial lung disease (ILD)\u002Fpneumonitis irrespective of steroid use, current ILD, ILD that cannot be ruled out by imaging at screening, or suspected ILD\n* Has clinically severe pulmonary compromise resulting from intercurrent pulmonary illnesses\n* Has history of clinically significant intracranial bleeding or spinal cord bleeding\n* Has active neurologic paraneoplastic syndrome\n* Has history of coronary\u002Fperipheral artery bypass graft and\u002For any coronary\u002Fperipheral angioplasty or clinically significant cardiovascular disease such as myocardial infarction, symptomatic congestive heart failure (CHF), and\u002For uncontrolled cardiac arrhythmia within 6 months before the first dose of study intervention\n* Has other uncontrolled or significant protocol specified cardiovascular disease\n* Has history of arterial thrombosis within 6 months before the first dose of study intervention\n* Has chronic liver disease\n* Has history of allogeneic tissue\u002Fsolid organ transplant\n* Has history of leptomeningeal disease\n* Is infected with human immunodeficiency virus (HIV) and has a history of Kaposi's sarcoma and\u002For Multicentric Castleman's Disease\n* Has received prior therapy with an anti-programmed cell death protein 1 (anti-PD-1), anti-programmed cell death ligand 1 (anti-PD-L1), or anti-programmed cell death ligand 2 (anti-PD-L2) agent or with an agent directed to another stimulatory or coinhibitory T-cell receptor\n* Has received prior radiotherapy within 2 weeks of start of study intervention, or has radiation-related toxicities, requiring corticosteroids\n* Has known additional malignancy that is progressing or has required active treatment within the past 3 years\n* Has active autoimmune disease that has required systemic treatment in the past 2 years except replacement therapy\n* Has known active central nervous system (CNS) metastases and\u002For carcinomatous meningitis\n* Has major surgery within 4 weeks or minor surgery within 2 weeks of allocation\u002Frandomization (or first dose), or is anticipated to require a major surgical procedure during the study","ALL","18 Years",{"count":825,"type":826},170,"ESTIMATED","INTERVENTIONAL",[829,830],"PHASE1","PHASE2","Researchers are looking for new ways to treat extensive-stage small cell lung cancer (ES-SCLC). ES-SCLC is a type of lung cancer that has spread throughout the lung, to the other lung, or to other parts of the body.\n\nA standard (usual) treatment for ES-SCLC uses both chemotherapy and immunotherapy.\n\n* Chemotherapy is a treatment that works to destroy cancer cells or stop them from growing.\n* Immunotherapy is a treatment that helps the immune system fight cancer.\n\nGocatamig and I-DXd (short for ifinatamab deruxtecan) are study medicines. Researchers want to know if giving gocatamig and I-DXd together can treat ES-SCLC. Researchers will also look at giving the study medicines with standard treatment. Gocatamig is a T-cell engager therapy. I-DXd is an antibody drug conjugate.\n\n* T-cell engager therapy is a certain type of immunotherapy that uses T-cells to find and destroy cancer cells.\n* A T-cell is a type of white blood cell, which are cells that help the body fight infection.\n* An antibody drug conjugate (ADC) is a treatment that attaches to a protein on cancer cells and delivers treatment to destroy those cells.\n\nThe goals of this study are to learn:\n\n* About the safety of combining gocatamig and I-DXd and if people tolerate them together\n* If people who receive gocatamig and I-DXd have ES-SCLC respond, which means the cancer gets smaller or goes away",[833],"Small Cell Lung Cancer Extensive Stage","2026-08-20",{"date":836,"type":837},"2026-08-21","ACTUAL",{"date":839,"type":837},"2026-01-29",{"date":841,"type":826},"2030-12-30",{"name":5,"class":6},52]